Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Alaunos Therapeutics
Acquired Company
Velaris Therapeutics
Houston
BeratBiotechnologyHealth CareBiotechnologyHealth CareTherapeuticsDescription
Alaunos Therapeutics has acquired Velaris Therapeutics in a strategic deal characterized as a reverse merger. This move aims to enhance Alaunos' operational capabilities and provide a strong financial foundation through a concurrent private stock offering. The merger focuses on advancing Velaris’ promising drug programs while integrating leadership from Fairmount Funds. This acquisition marks a significant step for both companies in the biotechnology sector.
Fundz sees it the moment Alaunos Therapeutics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Velaris Therapeutics?
Velaris Therapeutics was acquired by Alaunos Therapeutics, based in Houston. The deal was reported on October 13, 2026. Alaunos Therapeutics, Inc. operates in the biotechnology industry, focusing on the development of cell therapies for the treatment of various forms of cancer. Alaunos Therapeutics is publicly traded (TCRT) and operates in Biotechnology.
When did Alaunos Therapeutics acquire Velaris Therapeutics?
Alaunos Therapeutics's acquisition of Velaris Therapeutics was reported on October 13, 2026. Alaunos Therapeutics has acquired Velaris Therapeutics in a strategic deal characterized as a reverse merger. This move aims to enhance Alaunos' operational capabilities and provide a strong financial foundation through a concurrent private stock offering. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Velaris Therapeutics do?
Velaris Therapeutics is a biotechnology firm dedicated to developing unique treatment solutions for rare diseases. Their focus is on creating therapies that address significant unmet medical needs. It is privately held, operating in Biotechnology, and is based in Berat.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.